BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38526972)

  • 1. Epidemiology of Fontan-associated liver disease in Japan: Results from a nationwide survey in 2021.
    Ohfuji S; Tanaka A; Kogiso T; Kanto T
    Hepatol Res; 2024 Mar; ():. PubMed ID: 38526972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive biomarkers of Fontan-associated liver disease.
    Emamaullee J; Khan S; Weaver C; Goldbeck C; Yanni G; Kohli R; Genyk Y; Zhou S; Shillingford N; Sullivan PM; Takao C; Detterich J; Kantor PF; Cleveland JD; Herrington C; Ram Kumar S; Starnes V; Badran S; Patel ND
    JHEP Rep; 2021 Dec; 3(6):100362. PubMed ID: 34693238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Fontan-associated Liver Disease and Ethnic Disparities in Long-term Survivors of the Fontan Procedure: A Population-based Study.
    Emamaullee J; Martin S; Goldbeck C; Rocque B; Barbetta A; Kohli R; Starnes V
    Ann Surg; 2022 Sep; 276(3):482-490. PubMed ID: 35766375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of Fontan Associated Liver Disease in Childhood and Adolescence.
    Hansen JH; Khodami JK; Moritz JD; Rinne K; Voges I; Scheewe J; Kramer HH; Uebing A
    Semin Thorac Cardiovasc Surg; 2022; 34(2):642-650. PubMed ID: 33979666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease.
    Sagawa T; Kogiso T; Sugiyama H; Hashimoto E; Yamamoto M; Tokushige K
    Hepatol Res; 2020 Jul; 50(7):853-862. PubMed ID: 32219953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.
    Lewis MJ; Reardon LC; Aboulhosn J; Haeffele C; Chen S; Kim Y; Fuller S; Forbess L; Alshawabkeh L; Urey MA; Book WM; Rodriguez F; Menachem JN; Clark DE; Valente AM; Carazo M; Egbe A; Connolly HM; Krieger EV; Angiulo J; Cedars A; Ko J; Jacobsen RM; Earing MG; Cramer JW; Ermis P; Broda C; Nugaeva N; Ross H; Awerbach JD; Krasuski RA; Rosenbaum M
    J Am Coll Cardiol; 2023 Jun; 81(22):2149-2160. PubMed ID: 37257950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac MRI-Derived Inferior Vena Cava Cross-Sectional Area Correlates with Measures of Fontan-Associated Liver Disease.
    Gunsaulus M; Wang L; Haack L; Christopher A; Feingold B; Squires J; Horslen S; Hoskoppal A; Rose-Felker K; West S; Trucco S; Squires J; Olivieri L; Kreutzer J; Goldstein B; Alsaied T
    Pediatr Cardiol; 2024 Apr; 45(4):909-920. PubMed ID: 36454265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fontan-Associated Liver Disease: A Review.
    Heering G; Lebovics N; Agarwal R; Frishman WH; Lebovics E
    Cardiol Rev; 2024 Mar; ():. PubMed ID: 38477576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.
    Lemmer A; VanWagner L; Gasanova Z; Helmke S; Everson GT; Ganger D
    Congenit Heart Dis; 2019 Nov; 14(6):978-986. PubMed ID: 31369200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associated Factors of Liver Disease After Fontan Operation in Relation to Ultrasound Liver Elastography.
    Sethasathien S; Silvilairat S; Sittiwangkul R; Makonkawkeyoon K; Pongprot Y
    Pediatr Cardiol; 2020 Dec; 41(8):1639-1644. PubMed ID: 32740670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive Investigations for the Diagnosis of Fontan-Associated Liver Disease in Pediatric and Adult Fontan Patients.
    Fidai A; Dallaire F; Alvarez N; Balon Y; Clegg R; Connelly M; Dicke F; Fruitman D; Harder J; Myers K; Patton DJ; Prieur T; Vorhies E; Myers RP; Martin SR; Greenway SC
    Front Cardiovasc Med; 2017; 4():15. PubMed ID: 28396861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Fontan-Associated Liver Disease and Its Association With Mortality.
    Guerrero-Chalela CE; Therrien J; Grossman Y; Guo L; Liu A; Marelli A
    J Am Heart Assoc; 2023 Oct; 12(19):e024034. PubMed ID: 37776221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure - A Nationwide Survey in Japan.
    Kuwabara M; Niwa K; Toyoda T; Shirai T; Tateno S; Ohuchi H; Tanaka Y; Ichida F; Fujisawa T; Akagi T; Mori Y;
    Circ J; 2018 Mar; 82(4):1155-1160. PubMed ID: 29445059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic Alterations Precede Functional Hepatic Impairment as Determined by
    Schleiger A; Kramer P; Sallmon H; Jentsch N; Pileckaite M; Danne F; Schafstedde M; Müller HP; Müller T; Tacke F; Jara M; Stockmann M; Berger F; Ovroutski S
    Front Cardiovasc Med; 2021; 8():764009. PubMed ID: 35004881
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of Transient Elastography to Stage Fontan-Associated Liver Disease (FALD) in Adults with Single Ventricle Congenital Heart Disease Correction.
    Chemello L; Padalino M; Zanon C; Benvegnu' L; Biffanti R; Mancuso D; Cavalletto L
    J Cardiovasc Dev Dis; 2021 Sep; 8(10):. PubMed ID: 34677186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
    Kim MH; Nguyen A; Lo M; Kumar SR; Bucuvalas J; Glynn EF; Hoffman MA; Fischer R; Emamaullee J
    Transplantation; 2021 Jan; 105(1):18-22. PubMed ID: 32639398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Liver and Spleen Stiffness in Patients with Fontan Associated Liver Disease (FALD): A Case Series with Histopathologic Comparison.
    Padalino MA; Chemello L; Cavalletto L; Angelini A; Fedrigo M
    J Cardiovasc Dev Dis; 2021 Mar; 8(3):. PubMed ID: 33809668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Mid-Term Liver Disease After the Fontan Procedure.
    Oka N; Miyamoto T; Tomoyasu T; Hayashi H; Miyaji K
    Int Heart J; 2020 Sep; 61(5):979-983. PubMed ID: 32921662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FibroScan as a surveillance marker post-cavopulmonary anastomosis for single-ventricle physiology.
    Kumar R; Refai MIM; Thingnam SKS; Kumar R; Rameshbhai NS; Jha N; Ammar A; Sen D; Sehrawat S; Chauhan S
    Indian J Thorac Cardiovasc Surg; 2024 Jul; 40(4):419-423. PubMed ID: 38919189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.
    Schleiger A; Salzmann M; Kramer P; Danne F; Schubert S; Bassir C; Müller T; Müller HP; Berger F; Ovroutski S
    Pediatr Cardiol; 2020 Apr; 41(4):736-746. PubMed ID: 32006084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.